Northwestern Mutual Wealth Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-204
Closed -$16.3K 4153
2025
Q4
$16.3K Hold
204
﹤0.01% 2827
2025
Q3
$12.2K Buy
+204
New +$11K ﹤0.01% 2841

Other funds holding BIB

Northwestern Mutual Wealth Management's BIB Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2026, closing a stake of 204 shares — an estimated $16.3K sold.

Northwestern Mutual Wealth Management first reported a position in BIB in Q3 2025 and held it in 2 quarters. The position peaked at $16.3K in Q4 2025. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 204 ProShares Ultra NASDAQ Biotechnology shares in Q1 2026, an estimated $16.3K.
  • Northwestern Mutual Wealth Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2025 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's ProShares Ultra NASDAQ Biotechnology position peaked at $16.3K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.